Unraveling the structures and modes of action of bacterial toxins

Current Opinion in Structural Biology

Volumn 8, Issue 6, 1998, Pages 778-784

  Lacy, D Borden ^a   Stevens, Raymond C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BACTERIAL TOXIN; COLICIN; MEMBRANE RECEPTOR; NEUROTOXIN; SHIGA TOXIN;

ANIMAL CELL; BINDING SITE; CHANNEL GATING; CRYSTALLOGRAPHY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOXIN STRUCTURE;

ANIMALIA; ANTHRAX; BACTERIA (MICROORGANISMS);

EID: 0032441768     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(98)80098-5     Document Type: Article

References (58)

1. 5 toxins. Curr Opin Struct Biol 1995, 5:165-171.
2. 2. Gouaux E: Channel-forming toxins: tales of transformation. Curr Opin Struct Biol 1997, 7:566-573.
3. 3. Parker MW (Ed): Protein Toxin Structure. Austin, Texas: RG Landes Co; 1996.
4. 4. Lesieur C, Vecsey-Semjen B, Abrami L, Fivaz M, van der Goot FG: Membrane insertion: the strategies of toxins. Mol Membr Biol 1997, 14:45-64.
5. 5. Cabiaux V, Wolff C, Ruysschaert J-M: Interaction with a lipid membrane: a key step in bacterial toxins virulence. Int J Biol Macromol 1997, 21:285-298.
6. 6. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE: Structure of staphylococcal α-hemolysin, a heptameric transmembrane pore. Science 1996, 274:1859-1866.
7. 7. Czajkowsky DM, Sheng S, Shao Z: Staphylococcal α-hemolysin can form hexamers in phospholipid bilayers. J Mol Biol 1998, 276:325-330. The observation of a hexamer using atomic force microscopy, when a heptamer was observed using X-ray crystallography, raises the possibility of a polymorphic stoichiometry of subunits existing in vivo. The molecular mechanism by which this polymorphism could form and the role of the membrane in its formation need to be further investigated. The observation of incomplete oligomers, if they exist in vivo, could imply an alternate mechanism of action, more similar to that of the cholesterol-binding cytolysins.
8. 8. Rossjohn J, Feil SC, McKinstry WJ, Tsernoglou D, van der Goot G, Buckley JT, Parker MW: Aerolysin - a paradigm for membrane insertion of beta-sheet protein toxins? J Struct Biol 1998, 121:92-100.
9. 9. Gouaux E: α-hemolysin from Staphylococcal aureus: an archetype of β-barrel, channel-forming toxins. J Struct Biol 1998, 121:110-122.
10. 10. Parker MW, Buckley JT, Postma JPM, Tucker AD, Leonard K, Pattus F, Tsernoglou D: Structure of the Aeromonas toxin proaerolysin in its water-soluble and membrane-channel states. Nature 1994, 367:292-295.
11. 11. Cabiaux V, Buckley JT, Wattiez R, Ruysschaert J-M, Parker MW, van der Goot FG: Conformational changes in aerolysin during the transition from the water-soluble protoxin to the membrane channel. Biochemistry 1997, 36:15224-15232. The authors analyzed the structural changes associated with the proteolytic activation, oligomerization and membrane insertion of aerolysin using attenuated total reflection - Fourier transform IR spectroscopy and hydrogen-deuterium exchange. The results show significant movements upon activation but minor changes upon oligomerization and insertion.
12. 12. Rossjohn J, Raja SM, Nelson KL, Feil SC, van der Goot FG, Parker MW, Buckley JT: Movement of loop in domain 3 of aerolysin is required for channel formation. Biochemistry 1998, 37:741-746. Crystallography was used to show that an engineered cysteine double mutant of aerolysin forms a disulfide bond between a loop from domain 3 and a β sheet and thus prevents oligomerization. This supports a model whereby the movement of loop 3 precedes and facilitates oligomerization.
13. 13. Vecsey-Semjen B, Lesieur C, Mollby R, van der Goot FG: Conformational changes due to membrane binding and channel formation by staphylococcal α-toxin. J Biol Chem 1997, 272:5709-5717.
14. 14. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC: Crystal structure of the anthrax toxin protective antigen. Nature 1997, 385:833-838.
15. 15. Benson EL, Huynh PD, Finkelstein A, Collier RJ: Identification of residues lining the anthrax protective antigen channel. Biochemistry 1998, 37:3941-3948. Cysteine substitutions were made for 24 consecutive residues of the anthrax protective antigen D2L2 loop and were derivatized with MTS-ET and tested for changes in channel conductance. An alternating response in two stretches of residues supports a model in which the D2L2 loop from seven monomers rearranges to form a 14-stranded β barrel that spans the membrane.
16. 16. Wang X-M, Wattiez R, Mock M, Falmagne P, Ruysschaert J-M, Cabiaux V: Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane. Biochemistry 1997, 36:14906-14913. Attenuated total reflection - Fourier transform IR spectroscopy and hydrogen-deuterium exchange were used to follow changes in the secondary structures of protective antigen 63, edema factor (EF) and two EF mutants when exposed to lipid and variable pH.
17. 17. Wang X-M, Mock M, Ruysschaert J-M, Cabiaux V: Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a Fourier-transform infrared spectroscopy approach. Biochemistry 1996, 35:14939-14946.
18. 18. Parker MW, Pattus F: Rendering a membrane protein soluble in water: a common packing motif in bacterial protein toxins. Trends Biochem Sci 1993, 18:391-395.
19. 19. Huynh PD, Cui C, Zhan H, Oh KJ, Collier RJ, Finkelstein A: Probing the structure of the diphtheria toxin channel. J Gen Physiol 1997, 110:229-242. Forty nine of the fifty one residues in the translocation domain helical hairpin of diphtheria toxin were singly substituted with cysteine and derivatized with MTS. Results from channel conductance analysis indicate that the channel is not multimeric and that the helical hairpin may not even be helical within the membrane - suggesting an open, flexible, monomeric structure.
20. 20. Oh KJ, Zhan H, Cui C, Hideg K, Collier RJ, Hubbell WL: Organization of diphtheria toxin T domain in bilayers: a site-directed spin labeling study. Science 1996, 273:810-812.
21. 21. van der Goot FG, Gonzalez-Manas JM, Lakey JH, Pattus F: A 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A. Nature 1991, 354:408-410.
22. 22. Zakharov SD, Lindeberg M, Griko Y, Salamon Z, Tollin G, Prendergast FG, Cramer WA: Membrane-bound state of the colicin E1 channel domain as an extended two-dimensional helical array. Proc Natl Acad Sci USA 1998, 95:4282-4287. Numerous biophysical techniques were used to characterize the structural changes within the colicin E1 channel domain upon membrane binding. Results indicate an increase in the helical content but a decrease in the tertiary structure of the membrane state.
23. 23. Kienker PK, Qiu X-Q, Slatin SL, Finkelstein A, Jakes KS: Transmembrane insertion of the colicin la hydrophobic hairpin. J Membr Biol 1997, 157:27-37.
24. 24. Kim Y, Valentine K, Opella SJ, Schendel SL, Cramer WA: Solid-state NMR studies of the membrane-bound closed state of the colicin E1 channel domain in lipid bilayers. Protein Sci 1998, 7:342-348. Results from solid-state NMR spectroscopy were found to be consistent with the 38 residue helical hairpin of colicin E1 spanning perpendicular to the membrane.
25. 15N solid-state NMR investigation in uniaxially aligned phospholipid bilayers. Biochemistry 1998, 37:16-22. The alignments of the trans-membrane helices of colicin B and E1 were compared at different pHs and different bilayer phospholipid compositions. Results support the 'umbrella' model, whereby the helical hairpin penetrates perpendicular to the membrane.
26. 26. Sandvig K, van Deurs B: Endocytosis and intracellular sorting of ricin and shiga toxin. FEBS Lett 1994, 346:99-102.
27. 1 catalytic domain into the cytosol.
28. 28. Hazes B, Read RJ: Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 1997, 36:11051-11054. In this model, the A and B subunits of the toxin dissociate within the ER, exposing a hydrophobic surface that 'disguises' the A subunit as a misfolded protein. It enters the ER-associated degradation pathway, but escapes ubiquitin-mediated degradation due to a lack of lysine residues.
29. 29. Murzin AG: OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences. EMBO J 1993, 12:861-867.
30. 30. Rossjohn J, Buckley JT, Hazes B, Murzin AG, Read RJ, Parker MW: Aerolysin and pertussis toxin share a common receptor-binding domain. EMBO J 1997, 16:3426-3434.
31. 3-binding sites per B subunit of shiga-like toxin I and may explain how tight cell-surface binding could be achieved despite only weak binding to its soluble receptor.
32. 3OSE. A comparison was made to the crystal structure [31•], as the NMR structure only revealed binding at 'site 2'.
33. 3. An atomic understanding of the role of both the additional sugar moiety and the residues involved in binding specificity should provide a basis for therapeutic development.
34. 34. Vetter IR, Parker MW, Tucker AD, Lakey JH, Pattus F, Tsernoglou D: Crystal structure of a colicin N fragment suggests a model for toxicity. Structure 1998, 6:863-874. The structure of a colicin N fragment reveals a helical pore-forming domain, which is similar to those seen in other α-CFTs, and a novel receptor-binding domain. A model for binding and translocation is proposed.
35. 35. Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, Jansonius JN, Rosenbusch JP: Crystal structures explain functional properties of two E. coli porins. Nature 1992, 358:727-733.
36. 36. Raggett EM, Bainbridge G, Evans LJA, Cooper A, Lakey JH: Discovery of critical TolA-binding residues in the bactericidal toxin colicin N: a biophysical approach. Mol Microbiol 1998, 28:1335-1343. Binding studies using isothermal titration microcalorimetry and tryptophan fluorescence indicate that the isolated N-terminal domain of colicin N has a higher affinity for TolA than the holotoxin. This result and similarities to bacteriophage DNA transport systems led the authors to suggest that the TolA-binding site is revealed after 'primary receptor binding'. The TolA-binding site appears to be in a different location than previously thought.
37. 37. Merritt EA, Sarfaty S, Feil IK, Hol WGJ: Structural foundation for the design of receptor antagonists targeting Escherichia coli heat-labile enterotoxin. Structure 1997, 5:1485-1499. This paper presents the structure of heat-labile enterotoxin in complex with four receptor antagonists. These compounds represent promising leads as they preserve key toxin-sugar interactions and are considerably smaller than the GM1 receptor. In one case, the receptor antagonist displaces a conserved water molecule, perhaps accounting for the observed gain in affinity.
38. 38. Umland TC, Wingert LM, Swaminathan S, Furey WF, Schmidt JJ, Sax M: Structure of the receptor binding fragment Hc of tetanus neurotoxin. Nat Struct Biol 1997, 4:788-791. This paper describes the structure of the tetanus toxin binding domain and gives a discussion of structures with homologous folds and primary sequence conservation with the botulinum neurotoxin serotypes.
39. 39. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC: The crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 1998, 5:898-902. The crystal structure of botulinum neurotoxin type A provided a look at the overall architecture of the catalytic, translocation and binding domains, in addition to discussing how the observed structural features may affect toxicity.
40. 40. Murzin AG, Lesk AM, Chothia C: β-trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors, interleukins-1β and 1α and fibroblast growth factors. J Mol Biol 1992, 223:531-543.
41. 41. Wiener M, Freymann D, Ghosh P, Stroud RM: Crystal structure of colicin 1a. Nature 1997, 385:461-464.
42. 42. Oblatt-Montal M, Yamazaki M, Nelson R, Montal M: Formation of ion channels in lipid bilayers by a peptide with the predicted transmembrane sequence of botulinum neurotoxin A. Protein Sci 1995, 4:1490-1497.
43. 43. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R: Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993, 365:160-163.
44. 44. Parker MW, Pattus F, Tucker AD, Tsernoglou D: Structure of the membrane-pore-forming fragment of colicin A. Nature 1989, 337:93-96.
45. 45. Elkins P, Bunker A, Cramer WA, Stauffacher CV: A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1. Structure 1997, 5:443-458.
46. 46. Li J, Carroll J, Ellar DJ: Crystal structure of insecticidal δ-endotoxin from Bacillus thuringiensis at 2.5 Å resolution. Nature 1991, 353:815-821.
47. 47. Li J, Koni PA, Ellar DJ: Structure of the mosquitocidal δ-endotoxin CytB from Bacillus thuringiensis sp. Kyushuensis and implications for membrane pore formation. J Mol Biol 1996, 257:129-152.
48. 48. Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW: Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 1997, 89:685-692.
49. 49. Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG, Westbrook EM: The three-dimensional crystal structure of cholera toxin. J Mol Biol 1995, 251:563-573.
50. 50. Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BAM, Witholt B, Hol WGJ: Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991, 351:371-378.
51. 51. van den Akker F, Sarfaty S, Twiddy EM, Connell TD, Holmes RK, Hol WGJ: Crystal structure of a new heat-labile enterotoxin, LT-IIb. Structure 1996, 4:665-678.
52. 52. Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH, Read RJ: The crystal structure of pertussis toxin. Structure 1994, 2:45-57.
53. 53. Fraser ME, Chernaia MM, Kozlov YV, James MNG: Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 Å resolution. Nat Struct Biol 1994, 1:59-64.
54. 54. Stein PE, Boodhoo A, Tyrell GJ, Brunton JL, Read RJ: Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 1992, 355:748-750.
55. 55. Choe S, Bennett MJ, Fujii G, Curmi PMG, Kantardjieff KA, Collier RJ, Eisenberg D: The crystal structure of diphtheria toxin. Nature 1992, 357:216-222.
56. 56. Allured VS, Collier RJ, Carroll SF, McKay D: Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Å resolution. Proc Natl Acad Sci USA 1986, 83:1320-1324.
57. 57. Kraulis PJ: MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 1991, 24:946-950.
58. 58. Merritt EA, Murphy MEP: Raster3D version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D 1994, 50:869-873.